Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion type Assertion NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_head.
- NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion description "[Also the immunoreactivity of calretinin was intense in 75% of cases of canine and 100% of human Leydig cell tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_provenance.
- NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion evidence source_evidence_literature NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_provenance.
- NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion SIO_000772 25511291 NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_provenance.
- NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion wasDerivedFrom befree-2016 NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_provenance.
- NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_assertion wasGeneratedBy ECO_0000203 NP1248323.RA58hX5Uwy8L4TW5Fa7IIyLx3rLrH9732Su9lU1y8r8Rs130_provenance.